Paying user area
Try for free
AbbVie Inc. pages available for free this week:
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to AbbVie Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Goodwill and Intangible Asset Disclosure
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The composition of goodwill and intangible assets exhibited notable shifts over the five-year period. Overall, the combined value of goodwill and intangible assets decreased from US$108.330 billion in 2021 to US$88.281 billion in 2025, though not consistently. A significant portion of this value is attributable to goodwill and developed product rights.
- Goodwill
- Goodwill remained relatively stable between 2021 and 2023, fluctuating around US$32 billion. A substantial increase occurred in 2024, reaching US$34.956 billion, followed by a further increase to US$35.640 billion in 2025. This suggests potential acquisitions or reassessments of existing goodwill values during these periods.
- Developed Product Rights
- Developed product rights experienced a decline from US$88.945 billion in 2021 to US$75.142 billion in 2023. A partial recovery was observed in 2024, increasing to US$81.428 billion, and remained relatively consistent in 2025 at US$81.239 billion. This fluctuation may reflect impairment charges, successful product development, or changes in estimated useful lives.
- Definite-Lived Intangible Assets
- The gross carrying amount of definite-lived intangible assets decreased from US$97.432 billion in 2021 to US$83.333 billion in 2023, before increasing to US$89.743 billion in 2024 and remaining at US$89.592 billion in 2025. Simultaneously, accumulated amortization increased consistently throughout the period, rising from negative US$22.151 billion in 2021 to negative US$42.232 billion in 2025. Consequently, the net carrying amount of definite-lived intangible assets decreased significantly, falling from US$75.281 billion in 2021 to US$47.360 billion in 2025. This indicates substantial amortization expense impacting the reported value of these assets.
- Indefinite-Lived Intangible Assets
- Indefinite-lived intangible assets showed a modest increase over the period, rising from US$670 million in 2021 to US$5.281 billion in 2025. The most significant increase occurred between 2023 and 2024, jumping from US$303 million to US$5.202 billion. This suggests potential recognition of new indefinite-lived intangible assets or revisions to existing valuations.
- Intangible Assets, Net
- The net value of intangible assets decreased from US$75.951 billion in 2021 to US$52.641 billion in 2025. While there was a slight recovery in 2024 to US$60.068 billion, the overall trend is downward, driven primarily by the amortization of definite-lived assets and fluctuations in developed product rights.
In summary, the changes in goodwill and intangible assets reflect a complex interplay of factors, including amortization, potential impairments, acquisitions, and the recognition of new intangible assets. The increasing goodwill balance in the later years and the substantial rise in indefinite-lived intangible assets warrant further investigation.
Adjustments to Financial Statements: Removal of Goodwill
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The information presents a five-year trend of reported and adjusted financial figures for total assets and stockholders’ equity. A consistent divergence exists between the reported and adjusted values, primarily attributable to the removal of goodwill and intangible assets in the adjusted figures. This analysis focuses on the observed trends and their implications.
- Total Assets
- Reported total assets decreased from US$146,529 million in 2021 to US$133,960 million in 2025, representing an overall decline of approximately 8.6%. The decrease was most pronounced between 2021 and 2022, followed by a more gradual decline in subsequent years. Adjusted total assets exhibit a more substantial and consistent downward trend, decreasing from US$114,150 million in 2021 to US$98,320 million in 2025, a reduction of approximately 13.9%. The difference between reported and adjusted total assets widens over the period, indicating an increasing impact from the removal of goodwill and intangibles.
- Stockholders’ Equity
- Reported stockholders’ equity initially increased from US$15,408 million in 2021 to US$17,254 million in 2022, before experiencing a significant decline to a deficit of US$3,270 million by 2025. Adjusted stockholders’ equity, however, consistently shows a deficit that deepens over the five-year period. Starting at a deficit of US$16,971 million in 2021, the adjusted deficit grew to US$38,910 million in 2025. The magnitude of the adjusted deficit is considerably larger than any fluctuations observed in the reported equity, highlighting the substantial negative impact of removing goodwill and intangible assets from the equity calculation.
The consistent and widening gap between reported and adjusted figures suggests that a significant portion of the reported asset base and equity is comprised of goodwill and intangible assets. The adjustments reveal a considerably weaker underlying financial position when these items are excluded. The trend in adjusted stockholders’ equity is particularly concerning, as it indicates a deteriorating equity position over time, potentially raising questions about the company’s long-term solvency and financial stability when assessed without the inclusion of goodwill and intangibles.
- Overall Trend
- The analysis reveals a pattern of declining financial strength when goodwill and intangible assets are removed from the financial statements. While reported figures may present a more stable picture, the adjusted figures offer a more conservative and potentially realistic view of the company’s financial health. The increasing deficit in adjusted stockholders’ equity warrants further investigation into the underlying causes and potential implications for the organization.
AbbVie Inc., Financial Data: Reported vs. Adjusted
Adjusted Financial Ratios: Removal of Goodwill (Summary)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
The financial metrics demonstrate a notable impact from the adjustment for goodwill and intangible assets. Removing goodwill from the asset base results in improved efficiency and profitability ratios compared to the reported figures. Several key trends are observed over the five-year period.
- Total Asset Turnover
- Reported total asset turnover exhibited an initial increase from 0.38 in 2021 to 0.42 in 2022, followed by a slight decrease to 0.40 in 2023, and then another increase to 0.42 in 2024, culminating in 0.46 in 2025. The adjusted total asset turnover consistently presents higher values, beginning at 0.49 in 2021 and steadily increasing to 0.62 in 2025. This indicates that the company appears more efficient in generating revenue relative to its assets when goodwill is excluded from the calculation.
- Financial Leverage
- Reported financial leverage shows significant volatility. It decreased from 9.51 in 2021 to 8.04 in 2022, then increased substantially to 13.00 in 2023 and further to 40.65 in 2024. Adjusted financial leverage figures are unavailable for comparison.
- Return on Equity (ROE)
- Reported ROE experienced a substantial decline from 74.91% in 2021 to 68.60% in 2022, followed by a more dramatic decrease to 46.94% in 2023, and a significant increase to 128.66% in 2024. Adjusted ROE figures are unavailable for comparison.
- Return on Assets (ROA)
- Reported ROA decreased from 7.88% in 2021 to 3.61% in 2023, and continued to decline slightly to 3.15% in 2025, with a peak of 8.53% in 2022. Adjusted ROA consistently shows higher values than the reported ROA, starting at 10.11% in 2021 and remaining relatively stable, fluctuating between 4.27% and 4.75% from 2023 to 2025. This suggests that the company’s profitability relative to its assets is notably higher when goodwill is removed from the asset base.
The consistent difference between reported and adjusted ratios highlights the substantial impact of goodwill on the company’s financial performance as presented. The increasing adjusted asset turnover and ROA suggest improved operational efficiency and profitability when goodwill is excluded. The lack of adjusted financial leverage and ROE figures limits a complete comparative analysis.
AbbVie Inc., Financial Ratios: Reported vs. Adjusted
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Total asset turnover = Net revenues ÷ Total assets
= ÷ =
2 Adjusted total asset turnover = Net revenues ÷ Adjusted total assets
= ÷ =
An examination of the financial information reveals trends in both total asset values and associated turnover ratios over a five-year period. Reported total assets experienced a general decline from 2021 to 2025, while adjusted total assets exhibited a similar, though slightly more pronounced, decreasing trend. Concurrently, both reported and adjusted total asset turnover ratios demonstrated directional movement, with adjusted turnover showing a stronger positive trend.
- Reported Total Assets
- Reported total assets decreased from US$146,529 million in 2021 to US$133,960 million in 2025. The largest year-over-year decrease occurred between 2021 and 2022, with a reduction of US$7,724 million. Subsequent annual declines were more moderate, suggesting a slowing rate of asset reduction.
- Adjusted Total Assets
- Adjusted total assets followed a consistent downward trajectory, declining from US$114,150 million in 2021 to US$98,320 million in 2025. The rate of decrease was relatively stable across the period, averaging approximately US$1,500 million per year. This suggests consistent management of assets excluding goodwill and intangible assets.
- Reported Total Asset Turnover
- The reported total asset turnover ratio fluctuated between 0.38 and 0.46 over the five-year period. An initial increase from 0.38 in 2021 to 0.42 in 2022 was followed by a slight decrease to 0.40 in 2023, before rising again to 0.42 in 2024 and reaching 0.46 in 2025. This indicates a modest improvement in the efficiency of generating revenue from reported assets.
- Adjusted Total Asset Turnover
- The adjusted total asset turnover ratio exhibited a clear upward trend, increasing from 0.49 in 2021 to 0.62 in 2025. The most significant increase occurred between 2024 and 2025, rising from 0.56 to 0.62. This suggests a growing efficiency in utilizing assets, excluding goodwill and intangible assets, to generate revenue. The increasing ratio, coupled with decreasing adjusted total assets, indicates improved operational performance relative to the asset base.
The divergence between the trends in reported and adjusted total asset turnover suggests that changes in goodwill and intangible assets are influencing the overall reported turnover ratio. The consistent increase in adjusted turnover, despite declining adjusted assets, implies improved core operational efficiency. Further investigation into the composition of assets and revenue streams may provide additional insights.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 Financial leverage = Total assets ÷ Stockholders’ equity (deficit)
= ÷ =
2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted stockholders’ equity (deficit)
= ÷ =
The information presents a review of total assets and stockholders’ equity, both reported and adjusted, alongside associated financial leverage metrics from 2021 through 2025. A notable divergence exists between reported and adjusted figures for both assets and equity, significantly impacting the calculated leverage ratios.
- Total Assets
- Reported total assets decreased from US$146,529 million in 2021 to US$133,960 million in 2025. While there was a substantial decrease from 2021 to 2022, the decline moderated in subsequent years, with a slight increase observed between 2022 and 2023, followed by further declines. Adjusted total assets exhibit a similar downward trend, decreasing from US$114,150 million in 2021 to US$98,320 million in 2025, demonstrating a consistent reduction throughout the period.
- Stockholders’ Equity
- Reported stockholders’ equity experienced considerable volatility. It increased from US$15,408 million in 2021 to US$17,254 million in 2022, then decreased sharply to US$10,360 million in 2023 and further to US$3,325 million in 2024, ultimately resulting in a deficit of US$3,270 million by 2025. Adjusted stockholders’ equity consistently showed a deficit, deepening from US$16,971 million in 2021 to US$38,910 million in 2025, indicating a continuous erosion of adjusted equity.
- Financial Leverage
- Reported financial leverage increased substantially over the period. Starting at 9.51 in 2021, it decreased to 8.04 in 2022, then rose dramatically to 13.00 in 2023 and peaked at 40.65 in 2024. The absence of a 2025 value suggests a potential continuation of this upward trend. Adjusted financial leverage figures are not provided, but given the consistently negative and decreasing adjusted stockholders’ equity, it is reasonable to infer that adjusted leverage would also exhibit a significant and increasing trend. The large difference between reported and adjusted equity is the primary driver of the increasing reported leverage.
The substantial and diverging trends in adjusted versus reported equity suggest that a significant portion of the reported equity base is related to items excluded in the adjusted calculation, such as goodwill or intangible assets. The increasing reported financial leverage, coupled with the deepening adjusted equity deficit, warrants further investigation into the composition of assets and equity and the sustainability of the capital structure.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROE = 100 × Net earnings attributable to AbbVie Inc. ÷ Stockholders’ equity (deficit)
= 100 × ÷ =
2 Adjusted ROE = 100 × Net earnings attributable to AbbVie Inc. ÷ Adjusted stockholders’ equity (deficit)
= 100 × ÷ =
Reported stockholders’ equity exhibited an initial increase followed by a substantial decline over the observed period. Conversely, adjusted stockholders’ equity consistently decreased, moving from a significant negative value to an increasingly negative position. The reported return on equity (ROE) demonstrated volatility, while adjusted ROE figures are unavailable for the entire period.
- Stockholders’ Equity Trends
- Reported stockholders’ equity increased from US$15,408 million in 2021 to US$17,254 million in 2022. However, a marked decrease followed, with equity falling to US$10,360 million in 2023, US$3,325 million in 2024, and ultimately reaching a deficit of US$3,270 million in 2025. Adjusted stockholders’ equity began at a negative US$16,971 million in 2021 and progressively worsened, reaching a deficit of US$38,910 million by 2025. The divergence between reported and adjusted equity suggests significant adjustments are being made, potentially related to intangible assets or goodwill.
- Return on Equity Analysis
- Reported ROE was 74.91% in 2021, decreased to 68.60% in 2022, and then fell further to 46.94% in 2023. A substantial increase was observed in 2024, with reported ROE reaching 128.66%. Adjusted ROE values are not presented for any of the years, hindering a comprehensive comparison. The absence of adjusted ROE data limits the ability to assess the true profitability of the entity after accounting for the adjustments made to stockholders’ equity.
The consistent decline in adjusted stockholders’ equity, coupled with the lack of corresponding adjusted ROE figures, warrants further investigation. The significant difference between reported and adjusted equity suggests the adjustments are material and could be impacting the overall financial health of the entity. The volatility in reported ROE, particularly the large increase in 2024, should be examined in conjunction with the underlying drivers of the reported earnings and the equity position.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).
2025 Calculations
1 ROA = 100 × Net earnings attributable to AbbVie Inc. ÷ Total assets
= 100 × ÷ =
2 Adjusted ROA = 100 × Net earnings attributable to AbbVie Inc. ÷ Adjusted total assets
= 100 × ÷ =
The analysis reveals distinct trends in both reported and adjusted return on assets, alongside a consistent decrease in total asset values over the five-year period. A significant divergence exists between the reported and adjusted figures, suggesting the impact of goodwill and intangible assets on overall performance metrics.
- Total Assets
- Reported total assets demonstrate a declining trend, decreasing from US$146,529 million in 2021 to US$133,960 million in 2025. Adjusted total assets exhibit a similar pattern, falling from US$114,150 million to US$98,320 million over the same timeframe. The consistent reduction in both reported and adjusted asset bases warrants further investigation into potential divestitures, asset impairments, or accounting adjustments.
- Reported Return on Assets (ROA)
- Reported ROA initially increased from 7.88% in 2021 to 8.53% in 2022, before experiencing a substantial decline to 3.61% in 2023. This downward trend continued, with ROA stabilizing at approximately 3.15% - 3.17% between 2024 and 2025. The decrease suggests diminishing profitability relative to the reported asset base.
- Adjusted Return on Assets (ROA)
- Adjusted ROA mirrors the trend of the reported ROA, increasing from 10.11% in 2021 to 11.10% in 2022, followed by a decline to 4.75% in 2023. Similar to the reported ROA, the adjusted ROA stabilizes around 4.27% - 4.30% in the subsequent years. However, the adjusted ROA consistently remains higher than the reported ROA throughout the period, indicating that the inclusion of goodwill and intangible assets significantly lowers the overall return on assets.
- ROA Discrepancy
- The difference between reported and adjusted ROA widens as the period progresses, highlighting the increasing impact of non-operating assets on the reported financial performance. The consistent higher adjusted ROA suggests that core operational profitability is stronger when excluding the effects of goodwill and intangible assets. This discrepancy could be a key area of focus for investors and management, potentially indicating the need for a review of asset valuation and allocation strategies.
In summary, the observed trends indicate a declining asset base coupled with decreasing profitability, as measured by both reported and adjusted ROA. The significant and growing difference between the two ROA figures underscores the substantial influence of goodwill and intangible assets on the company’s reported financial performance.